EU opinion & policy debates - across languages | BlogActiv.eu

Archives for medicines

Why a ‘stand alone’ health programme is better for citizens’ health?

March 19, 2018

The EU’s budget line for EU health action (‘the Health programme’) will be either dismantled and mashed into the ‘soup’ of the Single Market with other ingredients such as food safety, animal, and plant health or will remain a stand-alone programme which would be actually better for citizens. Here is why. Cooking a healthy EU… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

Agriculture & Food, blogactiv, Civil Society (NGOs), EU Priorities 2020, Health & Consumers, medicines, Public Health, Regional Policy, Roma

How can EU trade policy ensure equitable access to medicines?

October 11, 2017

High medicine prices is a key public health challenge in Europe and Trade policy – an exclusive EU competence can improve or exacerbate the situation. Free Trade and Investment agreements can make easier or harder for European governments to change existing policies to curb the costs of pharmaceuticals. Following a civil society dialogue meeting with… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Global Europe, Health & Consumers, medicines, Public Health, Sustainable Dev.

,

Health is a Big Thing!

June 7, 2017

Genval, 6th June 2017. – The European Integration is at crossroads, the EU is suffering from many crises, its legitimacy is questioned by populist forces and in order to respond to that what is the best idea President Juncker and his team could come up with? Bingo! Scrap the tiny health programme to alienate even… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), European Integration, Health & Consumers, medicines, Public Health

TTIP and Health Sustainability: No Question Mark?

December 20, 2016

Genval, 18th December 2016 – According to the tiny human health case studies of an independent impact assessment, TTIP will not harm our health at all. I am wondering: how can an independent assessment come to that conclusion? According to the authors of the study, its impact on the trade of unhealthy commodities (alcohol, tobacco,… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Global Europe, Health & Consumers, medicines, Public Health, Sustainable Dev.

[Guest post] Will #TTIPLeaks make TTIP more sustainable?

May 3, 2016

(author – Adolfo Costantini) Rome, 2 May 2016. – The recent leak of confidential Transatlantic Trade and Investment Partnership (TTIP) documents by Greenpeace did not cover the planned Sustainable Chapter and it is worth to reflect upon if increased transparency will help making Trade agreements sustainable. The adoption of Sustainable Development Goals in New York… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

Agriculture, blogactiv, Global Europe, Health & Consumers, medicines, Public Health, Sustainable Dev.

Public Health in Europe – from my eyes

April 25, 2016

Genval, 24 April, 2016. – Disclaimer: These are the transcripts of an interview originally published on International Innovation (issue 163) in November 2014. The authentic version is available at the International Innovation website. How to improve the health status and life expectancy of Europe’s population while reducing health inequalities? Overview of my work as a… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Health & Consumers, medicines, Public Health

Why are Trade Secrets Harmful for Health?

April 12, 2016

Genval, 11th April 2016. – Because trade secret is so widely defined that it includes clinical trials data, and despite of vague exceptions, it can well affect clinical trials transparency which is key for patient safety and new drug development. There is no guarantuee that Pharmaceutical companies will not abuse it. Why are Trade Secrets… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Health & Consumers, medicines, Public Health

TTIP: the Road to Hell is Paved with Goodwill

March 30, 2016

Genval, 30 March, 2016. – Disclaimer: This is the English translation of an interview made by Mihail Călin and originally published on 25 September 2015. The authentic Romanian version is available at the euro-health.ro News/Media website. The Transatlantic Trade and Investment Partnership (TTIP) between the United States and the EU are surrounded by fierce controversy… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Consumer Protection, EU Priorities 2020, Global Europe, Health & Consumers, medicines, Public Health, Sustainable Dev.

Did We (Temporarily) Loose the Trade Secrets Directive?

February 1, 2016

Genval, 31st January 2016. – Is it really apropriate to raise this question, after the European Parliament’s Legal Affairs (JURI) Committee has endorsed a trilogue deal with the Council on Trade Secrets with an overwhelming political majority (EPP-S&D-ECR-ALDE-EFDD-ENF(!))? I think it is as I believe some of the key public interest concerns were not taken… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Health & Consumers, medicines, Public Health

Transatlantic Rupture during Transatlantic Dialogue?

January 28, 2016

Genval, 27th January 2016 – While attending yesterday the Transatlantic Consumer Dialogue (TACD) conference on the precautionary principle in the context of the Trade and Investment Partnership (TTIP) negotiations between the European Union and the United States, I have noted quite a few funny statements which made me think further. Here are some of them.… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Civil Society (NGOs), Consumer Protection, Global Europe, Health & Consumers, medicines, Public Health

Who cares about the health of refugees?

January 25, 2016

Genval, 22 January 2016 – Refugees have became the most popular scapegoat of European politics and the No.1 challenge of the European integration. While media focuses mainly on spectacular elements such as dismantling Schengen or emerging razor wire fences, little attention was paid to the health status of refugees so far. This is why I… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Global Europe, medicines, Public Health

[Guest Post] Who Will Swallow the Hard Pill? – TTIP and Access to Medicines in the EU

January 18, 2016

(author: Laureen Missaire) – The Transatlantic Trade and Investment Partnership, a controversial international trade agreement, is being negotiated at this moment and will have some major impact on society and particularly on public health. The negotiations started in July 2013 and the most recent 11th round of negotiations have taken place on 19-23 October 2015… » read more

  Posted by My European Civil Voice - Zoltán Massay-Kosubek @EU_ZMK

blogactiv, Health & Consumers, medicines, Public Health

Lifting the Veil in the European Medicines Agency

August 28, 2014

I wrote a number of blogs on the apparent change of policy on transparency by the European Medicines Agency when it published a new draft policy for targeted consultation last May – see here, here, and here for example. The Management Board of the agency were due to decide on this changes in June but… » read more

consumers, Ethics in Business, EU institutions, EU Priorities 2020, health, Health & Consumers, Innovation and Growth, medicines, pharmaceuticals, Public Affairs, Science & Research, Trade & Industry

Germany’s Bayer to buy Merck’s OTC business for $14.2 bn

May 6, 2014

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin painkiller, said on Tuesday it will acquire the consumer care business of Merck and Co in the US for $14.2 billion. “Bayer has agreed to acquire the consumer care business of US pharmaceutical company Merck and Co., for a purchase price of $14.2 billion (10.4 billion… » read more

Bayer, Brands, Categories, euros, German, health, Healthcare, medicines, Merck, Milestone, pharmaceutical, Products, world

, ,

EurActiv Network